NCT05605535 2025-07-11Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian CancerCanariaBio Inc.Phase 2 Active not recruiting88 enrolled
NCT05335993 2025-07-10A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.CanariaBio Inc.Phase 2 Active not recruiting10 enrolled